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Abstract
Background: Pain is one of the most commonly reported symptoms in people living with HIV/AIDS, whether or
not they are receiving anti-retroviral therapy. A recent systematic review identified a paucity of studies exploring
pain in women in low and middle income countries. The prevalence and characteristics of pain in women living
with HIV/AIDS may differ from that of men as many chronic pain conditions are more prevalent in women. The
aims of this study were to establish pain prevalence, characteristics and management in amaXhosa women living
with HIV/AIDS. In addition, we aimed to identify whether there were associations between pain in this population
and the psychosocial factors of employment, education, self-efficacy, depression, post-traumatic stress disorder,
health related quality of life and childhood trauma.
Methods: A cross-sectional study of 229 women who had undergone HIV testing and were registered patients at a
community health centre was conducted. Data were collected by interview with a demographic questionnaire, the
Brief Pain Inventory-Xhosa, Childhood Trauma Questionnaire–Xhosa, Harvard Trauma Questionnaire–Xhosa for PTSD,
Self-Efficacy for Managing Chronic Disease 6-Item Scale-Xhosa; the EQ-5D health related quality of life instrument,
and the Beck Depression Inventory.
Results: 170 of the women had pain, a prevalence rate of 74.24% (95%CI 68.2 – 79.47%). The women reported
significant pain with pain severity of 5.06 ± 1.57 and pain interference of 6.39 ± 1.96 out of 10. Only two women
were receiving adequate pain management according to the pain management index. Participants reported a
mean of 2.42 ± 1.21 different anatomical sites of pain. There were more unemployed participants in the group with
pain and they had significantly fewer years of schooling. Those with pain had lower self-efficacy; health related
quality of life and increased depression and PTSD symptom severity.
Conclusion: This study highlights that pain is a common problem for amaXhosa women living with HIV/AIDS.
These data emphasise the need to prioritise pain assessment and management in amaXhosa women living with
HIV/AIDS. Routinely assessing for the presence of pain in women with HIV/AIDS has the potential to improve pain
management and minimise the impact of pain on function.
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Background
Pain is one of the most commonly reported symptoms
in people living with HIV/AIDS (PLWHA), whether or
not they are receiving highly active anti-retroviral ther-
apy (HAART) [1]. In a recent systematic review, we re-
ported the pooled one-week prevalence of pain in
PLWHA as 60.81% [95%CI (58.55–63.025)] with several
studies reporting on the inadequate management of pain
in this population [1–6]. In the systematic review we
highlighted the high proportion of studies reporting on
pain prevalence in ambulatory PLWHA from high in-
come countries where men make up the majority of the
infected population and transmission is predominantly
through homosexual contact and intravenous drug use.
The review identified a paucity of studies exploring pain
in ambulatory PLWHA in low and middle income coun-
tries, and in particular in women in these countries. In
addition to a lack of information on the prevalence of
pain in women living with HIV/AIDS, previous studies
lacked a systematic methodological approach indicating
a need for studies using the STROBE guidelines [7].
The prevalence of pain in women living with HIV/AIDS
may differ from that of men as many chronic pain condi-
tions are more prevalent in women [8]. While these higher
prevalence rates may be a reflection of cultural acceptance
for women to report pain, it may be a consequence of dif-
ferences in physiology between men and women. Physio-
logical differences between men and women contribute to
different responses to nociceptive input and women are
known to have different responses to pharmacological and
non-pharmacological treatments for pain [9–11]. There-
fore, not only may the prevalence of pain in women living
with HIV/AIDs differ from that in men, the characteristics
of that pain may also be different.
In addition to pain being different between men and
women, the prevalence, characteristics and impact of
pain may differ in different cultural groups. Several st-
udies have reported on the effects of culture and gender
on pain experience in different ethnic and social groups
[12, 13]. Studies exploring differences between African-
American and Caucasian American groups have identi-
fied differences in pain prevalence in both healthy adults
and chronic pain populations with African-American
populations having a higher prevalence of chronic pain
[12, 14]. Further, differences in patterns of pain preva-
lence in PLWHA from different cultures have been re-
corded in studies in South African populations [15]. In
addition to differences in pain prevalence in different
cultures, prevalence of pain in people living with HIV/
AIDS has also been associated with depression, a history
of trauma and low levels of quality of life [2, 5, 16], and
a greater number of symptoms are associated with a lack
of income [17]. All these risk factors are widespread in
South African society.
In South Africa, not only is the HIV+ population pre-
dominantly female (60%), the majority have also not
completed secondary level education, both factors which
may well increase their risk for pain [5]. If the influence
of gender and ethnic group on pain prevalence is ac-
knowledged, then pain research which focusses on cul-
tural and ethnic gender-specific groups is apt. Previous
studies conducted exploring the prevalence of pain in
PLWHA in South Africa have considered people from
the Zulu, Venda and Tswana groups cultures [5]. The
Xhosa are the largest cultural group in the Western
Cape of South Africa with a population of approximately
nine million people, approximately two million who have
HIV. Members of the Xhosa refer to themselves as
amaXhosa while the language is referred to as isiXhosa.
The lack of evidence on pain in women living with
HIV/AIDS and particularly in women from developing
countries, led us to design a study with the aim of estab-
lishing pain prevalence, characteristics (sites and sever-
ity) and management in amaXhosa women living with
HIV/AIDS. In addition, we aimed to identify whether
there were associations between pain in amaXhosa
women living with HIV/AIDS and the psychosocial fac-
tors of employment, education, self-efficacy, depression,
health related quality of life and history of trauma
(PTSD or childhood trauma).
Method
A clinical analytical descriptive study was conducted using
a cross-sectional design.
Setting and Subjects
This study was conducted in the community of Khayelit-
sha, South Africa. At the time of this study, this commu-
nity had an estimated population of half a million people
of whom 75% were under the age of 35 [18]. Overall, the
unemployment rate as estimated to be 60–70%. The ma-
jority of residents of this community lived in shacks
made from corrugated iron while 30% lived in houses
built on separate plots. Nearly 40% of residents did not
have water at their homes and made use of communal
taps and communal toilets. Up to 75% of residents had
electricity with the remainder relying on paraffin stoves
and lanterns for cooking, heat and light [18].
The community health centre (CHC) where the study
was conducted falls under the provincial department of
health. The centre provides emergency services, has a
midwife and obstetric unit, a pharmacy, an HIV HAART
clinic, physiotherapy, occupational therapy and a school
health service among others. The HAART clinic at this
community health centre is well established with over
4000 patients attending each month for free monitoring
and treatment [19]. The study focused on amaXhosa
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women from this community, living with HIV/AIDs and
receiving treatment at the CHC.
Following identification of a CHC with an established
HAART clinic as a site for data collection, sample size
was calculated based on the lowest expected prevalence
of pain. Between 1 July 2009 and 31 July 2009, 2356
women were treated at the HIV clinic. Using the 60.81%
prevalence reported in the systematic review as the low-
est expected prevalence of pain, sample size was calcu-
lated using Epi Info® (Version 7). For a population of
2356, using a 5% precision and a confidence interval of
90%, a sample of 234 was required to ensure adequate
power. Based on these data, a target of 250 participants
was set for the study.
A sample of convenience was utilized. AmaXhosa
women aged 18 to 40 years, who had undergone HIV
testing and were registered patients at the CHC HAART
clinic, were approached to take part in a study exploring
quality of life in amaXhosa women living with HIV/
AIDS. Inclusion criteria comprised being female, a first
language IsiXhosa speaker, HIV positive (all clinical
stages) and between 18–40 years old. Women over the
age of 40y were excluded from the study as the preva-
lence of co-morbidities such as osteoarthritis, hyperten-
sion and diabetes increase from this age which would
potentially confound the results [20]. As information
was gathered by interview, literacy was not a require-
ment. Exclusion criteria included having moderate to se-
vere intellectual disability as recorded in their medical
records, or cognitive impairment restricting ability to
participate in an interview.
A research assistant (RA) fluent in IsiXhosa and English
was employed to conduct the data collection by interview.
All interviews were conducted in IsiXhosa.
Procedure
Ethical approval was obtained from both the Faculty of
Health Sciences Research Ethics Committee of the Uni-
versity of Cape Town (HREC Ref: 420 2007) and the
Province of the Western Cape Department of Health
(Reference number: 19/18/RP12/2009).
Recruitment of participants took place during clinic
hours between Mondays and Fridays from 8 am to
2 pm. These are the peak times of the clinic and recruit-
ment was aimed at all those attending the clinic for
scheduled appointments. Women attending for routine
monitoring of their condition were approached by the
RA while waiting for their files to be processed. The RA
invited the women to take part in a study exploring
quality of life in PLWHA which would involve a one-
hour interview prior to their routine clinic consultation.
Pain was expressly not mentioned in the recruitment
process. Patients who expressed an interest were pro-
vided with an information sheet and were given the
opportunity to have any questions answered by the RA
prior to completing informed consent.
Participants were interviewed by the RA in a private
setting. Data were collected using a demographic ques-
tionnaire to establish age, level of education, employ-
ment, marital status and health status including time
since diagnosis, CD4+ count and HAART management
as well as the presence of co-morbidities including op-
portunistic infections. The Brief Pain Inventory-Xhosa
(BPI-Xhosa) [21], the Childhood Trauma Question-
naire–Xhosa (CTQ-Xhosa), The Harvard Trauma Ques-
tionnaire–Xhosa (HTQ-Xhosa), the Self-Efficacy for
Managing Chronic Disease 6-Item Scale (SE-6-Xhosa);
the EQ-5D health related quality of life instrument, and
the Beck Depression Inventory (BDI) were administered
by interview. The BPI-Xhosa is a useful instrument for
measuring the prevalence of pain as its first question
asks: “Throughout our lives, most of us have had pain
from time to time (such as minor headaches, sprains,
and toothaches). Have you had pain other than these
everyday kinds of pain during the last week?” The BPI-
Xhosa is a valid measure of pain in urban amaXhosa
women with good internal reliability [21]. The remaining
instruments have also been validated for use in urban
amaXhosa demonstrating good validity and reliability
[22, 23]. The RA accessed the patient’s folder once all
clinical documentation had been completed to obtain
the most recent medical information including records
of co-morbidities and/or opportunistic infections (dia-
betes, hypertension, peripheral neuropathy, tuberculosis,
candidiasis, other) in the past year.
Data analysis
The STROBE guidelines were used to inform the design,
analysis and presentation of data [7]. Descriptive statis-
tics were calculated using summary statistics and fre-
quency distributions where appropriate. The prevalence
of pain is reported as the percentage with 95% confi-
dence intervals. The pain management index (PMI), a
crude measure of the adequacy of pharmacological pain
management, was calculated using the formula described
by the developers of the BPI [24]. To calculate the PMI,
PSS are assigned a score of 0, 1, 2, or 3 with PSS of 1–4
= 1, PSS of 5–6 = 2 and PSS of 7–10 = 3. Using the
World Health Organisation guidelines, analgesic medica-
tions are allocated scores according to strength with no
pain medication = 0, non-opioids = 1, “weak’ opioids = 2,
and “strong” opioids = 3. The PMI score is calculated by
subtracting the pain score from the analgesic score. A
negative PMI score was considered an indicator of po-
tentially inadequate pain management by the prescriber.
Data were examined for normality and subsequently
comparisons were performed between those with pain
(pain group) and those without pain (pain free group)
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for each of the numerical variables theorised to contrib-
ute to the presence of pain (self-efficacy, HRQoL, de-
pression, childhood trauma and PTSD). Where data
were normally distributed, differences between the groups
(pain group and pain free group) were calculated using t-
tests for parametric interval data and chi-squared tests for
nominal and ordinal data; for data not normally distrib-
uted, differences between groups were calculated using
the Mann–Whitney U test. The relationships between
pain severity and numeric psychosocial variables were
assessed using Spearman’s rank correlations. Spearman’s
rho (rs) correlations were interpreted as weak (−0.3–-0.1
and 0.1–0.3), moderate (−0.5–-0.3 and 0.3–0.5) and strong
(−1.0–-0.5 and 0.5–1.0) [25]. All data are presented as the
mean ± standard deviation. Statistical significance was
accepted as p < 0.05.
Results
Data were collected between 1 February 2010 and 3 De-
cember 2010. No data collection took place between 19
August, 2010 and 16 Sept, 2010 due to a strike in the
public health sector which disrupted service delivery at
the research site. Data collection in the time immediately
following the strike action was reduced due to lack of
capacity at the clinic. Data collection was not conducted
during the summer holiday month of December 2010
due to markedly decreased attendance at the clinic dur-
ing this time (this decrease in turnover occurs on a
yearly basis as a consequence of summer vacations).
Socio-economic, demographic and clinical characteristics
of the sample (N = 229)
Of the 2356 women registered with the clinic, 248 were
approached and recruited for the study, 245 met the inclu-
sion criteria (three of those recruited were over the age
limit) (Fig. 1). Data from 16 women were not included in
the final analysis due to withdrawal during the interview
or the RA being unable to trace the medical folder. The
final sample consisted of 229 amaXhosa women with
HIV/AIDS aged between 18–40 years of age. The mean
age of the participants was 30.7 ± 4.8y with no difference
in age between those with pain and those without pain.
The majority of participants were single (61.57%) and
could speak more than two languages.
Prevalence of pain
In this sample of amaXhosa women living with HIV/
AIDS, prevalence of pain was 74% (95%CI 68–79%)
when the women were asked the first screening question
from the Brief Pain Inventory–Xhosa.
Characteristics of Pain
The full Brief Pain Inventory–Xhosa was completed by
the 170 women who responded “Yes” to the screening
question on the BPI-Xhosa. The Pain Severity Score
(PSS) was calculated as the mean of the worst pain, least
pain, average pain and pain now as described by the au-
thors of the instrument [24]. Similarly, the Pain Interfer-
ence Score (PIS) was calculated as the mean of the seven
items relating to pain interference. As presented in
Table 1, the 170 women with pain were experiencing
moderate pain severity and moderate pain interference
with function with severe episodes of pain (worst pain =
7.52 ± 1.73 and pain interference with enjoyment of life =
7.07 ± 2.46) [21].
Sites of pain
On the body chart of the BPI, the women indicated a
mean of 2.42 ± 1.21 (median 2; range 1–6) different ana-
tomical sites of pain. The frequency of the most
Fig. 1 The sampling process
Parker et al. BMC Women's Health  (2017) 17:31 Page 4 of 11
commonly reported different anatomical areas are pre-
sented in Fig. 2. The most frequently reported region of
pain was the head/neck region (92 participants) followed
by the abdomen (56 participants).
Pain management
The mean score on the Pain Management Index was −1.62
± 0.66 (median −2, range −3–0). The distribution of PMI
scores are presented in Fig. 3. Of the 170 women with pain,
two were receiving adequate pharmacological analgesic
management for their pain according to WHO guidelines.
The most commonly used analgesic was paracetamol,
used by 104 (61%) of those with pain. Non-steroidal
anti-inflammatory drugs (NSAIDs) were used by 10 (6%)
while a combination of paracetamol and NSAIDs were
used by 23 (14%) of those with pain. No analgesics were
being used by 25 (15%) while the remainder were using
a combination of paracetamol and adjuvant drugs (2),
paracetamol and a weak opiate (5) and one woman was
using paracetamol and a strong opiate. Pain relief
obtained from medication is measured on the BPI on a
0%–100% VAS. The mean pain relief obtained from tak-
ing analgesic medication (n = 162) was 58.58 ± 18.87%
(median 60%, range 0–100).
Factors associated with pain
Those with pain had significantly less time at school than
those without pain (10.18 ± 1.76 years of schooling vs.
10.93 ± 1.35 years of schooling; t = −2.98; p < 0.01). With
regard to employment, 66% of the participants were un-
employed with significantly more women with pain being
unemployed (67% vs 62%; χ2 = 16.99; p = 0.03). There was
no difference between groups in health status (Table 2).
The psychosocial factors of self-efficacy, depression,
health related quality of life, risk of PTSD or a history of
childhood trauma which are known to contribute to the
prevalence of pain were explored (Table 3). Compared
to those without pain, the women with pain had worse
scores for self-efficacy (p = 0.02), depression (p < 0.01);
health related quality of life (p < 0.01) and risk of post-
traumatic stress disorder (p = 0.03).
Following identification of differences in the numeric
variables of number of years of schooling, self-efficacy,
Table 1 Pain Severity Scores and Pain Interference Scores from
the BPI-Xhosa (n = 170)
Mean ±
SD
Pain Severity Score (mean of worst, least, average, now) 5.06 ± 1.57
Worst pain 7.52 ± 1.73
Least pain 4.65 ± 1.73
Average pain 3.93 ± 1.86
Pain now 4.14 ± 2.69
Pain Interference Score (mean of pain interference with
activity, mood, walking, normal work, relations, sleep and
enjoyment of life)
6.39 ± 1.96
Pain interference with activity 6.52 ± 2.56
Pain interference with mood 6.63 ± 2.76
Pain interference with ability to walk 6.18 ± 2.77
Pain interference with ability to do normal work 6.11 ± 2.68
Pain interference with relations with other people 5.89 ± 2.96
Pain interference with sleep 6.56 ± 2.78
Pain interference with enjoyment of life 7.07 ± 2.46
Pain Severity Scores and Pain Interference Scores range from 0–10 with higher
scores indicating greater pain severity or greater pain interference
with function
Data previously published in Parker at al (2016) [21]
Fig. 2 Frequency of most commonly reported painful anatomical areas. (Reprinted with permission, Copyright 1991 Charles S. Cleeland, PhD) [24]
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health related quality of life (EQ-5D index), depression
(BDI) and PTSD in women reporting pain compared
with those not reporting pain, relationships between
each of these variables and pain severity (PSS) and pain
interference (PIS) were explored using a correlation
matrix (Table 4). There were weak to moderate negative
relationships between both pain severity and interfer-
ence, and years of schooling and health related quality of
life (EQ5D index), and weak to moderate positive rela-
tionships between pain severity and interference and de-
pression. There was a weak positive relationship
between the women’s scores for PTSD and pain interfer-
ence. Finally, there was no association between self-
efficacy and with pain severity or interference.
Discussion
In this sample of amaXhosa women living with HIV, a
pain prevalence rate of 74.24% (95%CI 68.2–79.47%) was
recorded. The women were experiencing moderate pain
with mean pain severity scores of 5.06 ± 1.57 and mean
pain interference scores of 6.39 ± 1.96. The women re-
ported a mean of 2.42 ± 1.21 different anatomical sites of
pain on the body chart with the most common anatom-
ical region of pain being the head/neck area (reported by
92 women) followed by abdominal pain (56 women).
Pain severity and interference was correlated to years of
education, health related quality of life and depression.
The 74% prevalence of pain in this sample was mark-
edly higher than the 60% prevalence of pain reported in
the systematic review of prevalence of pain in PLWHA
[1]. However, this figure is similar to the 72% prevalence
of pain reported in an ambulant HIV positive rural co-
hort of South Africans [5]. There are several factors
which may explain why the pain prevalence rate was
higher than the 60% obtained from the pooled data in
the systematic review. The first lies with the gender of
the sample. Several studies have identified differences in
nociceptive pain processing between men and women in
addition to higher prevalence of many different painful
conditions in women [26–29]. Essentially, being female
increases risk for developing pain. Thus the higher preva-
lence of pain in this sample may simply be a reflection of
this increased risk for pain among women and an indica-
tion of how much being female increases risk for pain. The
second factor relates to the socio-economic status of the
women. Socio-economic status has also been identified as a
risk factor for pain [30]. More than half of the women were
unemployed (66%) and the significantly higher rates of un-
employment in the women with pain suggest that this may
have been a contributing factor. Finally, previous studies
have identified low levels of education as increasing risk for
pain [31, 32]. The majority of the sample in the present
study had not completed all 12 years of schooling in South
Africa, with those reporting pain having significantly lower
levels of education than those without pain.
Fig. 3 Pain Management Index Scores (n = 170)
Table 2 Health status of participants with pain and without
pain
Pain group Pain Free
Group
Mean ± SD Mean ± SD Significance
Test
Most recent CD4+ count n = 16 n = 56
cells/microL 5328.36 ±
206.97
338.68 ±
227.55
t = 0.31;
p = 0.75
Time since diagnosis n = 10 n = 40
Years 4.3 ± 3.3 3.8 ± 3.2 t = 1.01;
p = 0.31
Time since initiating
treatment
n = 169 n = 57
Months 24.5 ± 22.3 21.9 ± 18.1 t = 0.57;
p = 0.57
Number (%) Number (%)
Current Clinical
Stage (I – IV)
n = 162 n = 55 χ2 = 1.41;
p = 0.23
HIV+ (Stage I and II) 59 (36) 25 (45)
AIDS (Stage III and IV) 103 (64) 30 (55)
Current HIV/AIDS
Management
n = 169 n = 57 χ2 = 12.12;
p = 0.02
Monitoring 17 (10.00) 3 (5.08)
First Line ARVs 137 (80.59) 44 (74.58)
Second Line ARVs 12 (7.06) 3 (5.08)
Pregnancy Prophylaxis 2 (1.18) 4 (6.78)
Defaulted 1 (0.59) 3 (5.08)
Opportunistic Infections
Tuberculosis 19 (11) 2 (3) χ2 = 3.18;
p = 0.07
Candidiasis 7 (4) 2 (3) χ2 = 0.06;
p = 0.8
Other infections
(genital herpes, papular
pruritic eruptions,
meningitis, pneumocystis
pneumonia, arthralgia)
10 (6) 0 (0) χ2 = 3.63;
p = 0.06
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Previous studies have repeatedly found few links be-
tween disease parameters and pain in PLWHA [33]. This
was also the case for the women in this study with no
differences in clinical stage between those with pain and
without pain and no differences in most recent CD4+
count and length of time since initiating treatment.
There was a difference between groups in HIV/AIDS
management with a larger proportion of those with pain
only being monitored for their condition. However,
given that there was no difference in CD4+ counts be-
tween the groups, it does not seem logical to suggest
that an increase in pain is a consequence of a lack of
treatment as the disease indicators do not correspond.
Pain severity and pain interference
The mean PSS (5.06 ± 1.57) indicates that the women
had moderate pain, pain recognised to interfere with
cognition and function suggesting that the pain experi-
enced by this group was severe enough to affect their
quality of life and require treatment [34]. The mean
score for the category of worst pain was 7.52 ± 1.73, in-
dicating severe pain and greater levels of suffering. Con-
sidering the severity of pain these women were
experiencing, it is particularly concerning that they were
not receiving adequate analgesia. It can be suggested
that the lack of pharmacological treatment may well
have contributed to the scores for pain interference
(6.39 ± 1.96) which indicates moderate interference with
life roles as a result of pain. In an era where treatment
of PLWHA has shifted to minimising the effect of symp-
toms in order to maximise quality of life, the under-
treatment of pain in these women and its impact on
their function is concerning.
There was only a moderate correlation between PSS
and PIS; suggesting that pain severity is not the only fac-
tor contributing to how these women cope with their
pain. This relationship between pain severity and pain
interference reinforces the findings of Mphahlele and
colleagues who reported on the stoicism of their partici-
pants who, despite moderate to severe levels of pain, re-
ported low to moderate levels of PIS [5]. This was
particularly notable in their participants from a rural
area, with the authors theorising that perhaps living con-
ditions were such that participants could not afford to
allow pain to interfere with their function as this would
impact on basic survival. The lack of association be-
tween pain severity and disability is recognised in the lit-
erature relating to musculoskeletal pain and cancer pain
with disability relating more to psychosocial factors such
as catastrophic thinking and beliefs about pain than with
the severity of pain [35]. Thus in a disadvantaged group
of women, it may be proposed that pain interference is
influenced by a multitude of variables such as cultural
beliefs, education and socio-economic level and is not
simply a direct consequence of pain severity.
Sites of pain
The number of different sites of pain reported by the
women on the body chart (>2) is a phenomenon which
appears throughout previous studies describing pain in
PLWHA [1]. The widespread anatomical sites of pain are
noteworthy as the literature suggests that pharmacological
Table 3 Associations between psychosocial factors and pain (N = 229)
Pain group (n = 170) Pain Free Group (n = 59)
Mean ± SD Mean ± SD Significance Test
Self-efficacy 6.45 ± 1.60 7.00 ± .51 t = −2.4; p = 0.02*
Health related quality of life (EQ5D) 0.683 ± 0.248 0.932 ± 0.101 t = −7.48; p < 0.01*
Depression (BDI) 18.5 ± 10.4 12.6 ± 9.0 t = 3.9; p < 0.01*
Harvard Trauma Questionnaire (PTSD) 1.78 ± 1.1 1.41 ± 1.1 t = 2.22; p = 0.03*
Childhood Trauma 41 ± 9 39.8 ± 10 t = 0.85; p = 0.39
bold* indicates significance at p < 0.05
Table 4 Correlation matrix for pain and biopsychosocial variables (n = 170)
PSS PIS Years of school SE-6-Xhosa EQ5D index BDI HTQ
Pain Severity Score (PSS) 1.00
Pain Interference Score (PIS) 0.35* 1.00
Years of school −0.25* −0.20* 1.00
Self-efficacy (SE-6-Xhosa) −0.04 −0.13 0.04 1.00
Health related quality of Life (EQ5D index) −0.35* −0.37* 0.25* 0.22* 1.00
Depression (BDI) 0.20* 0.44* −0.22* −0.27* −0.44* 1.00
Post-traumatic stress disorder (HTQ) 0.10 0.19* −0.12 0.11 −0.21* 0.36* 1.00
bold* indicates significance at p < 0.05
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management of pain in PLWHA focuses on painful per-
ipheral neuropathy which presents with bilateral foot pain
followed by bilateral hand pain when severe [36–43].
However, the varied sites of pain suggest that these
women are suffering from causes of pain other than per-
ipheral neuropathy. Their pain may be directly related to
HIV, or, it may arise from unrelated co-morbidities such
as osteoarthritis or be idiopathic in nature.
Pain is a cortical construct or output of the brain pro-
posed to be produced by a threat neuromatrix (previ-
ously viewed as a pain neuromatrix) [44]. If pain is
approached from a standpoint of being a construct in re-
sponse to threat, it may be hypothesised that PLWHA
are more vulnerable to suffering from pain, not as a dir-
ect result of increased sources of nociception, but as a
consequence of the individual being under threat. This
may explain the high prevalence rates of pain in this
population and the multiple sites of pain reported by
PLWHA. Approaching pain management from an un-
derstanding of pain as an expression of threat may be a
useful theory in developing treatment plans for PLWHA
with pain; treatment plans which include both pharma-
cological approaches but also non-pharmacological in-
terventions. The data from this study and others on pain
in PLWHA indicate that further research into effective
management approaches is needed in order to address
the widespread pain experienced.
Pain management
While it must be acknowledged that the PMI is a crude
measure of the adequacy of pharmacological pain man-
agement, it is notable that only two women in this study
were receiving adequate analgesic therapy. This is not a
unique finding and it is disconcerting considering that
the under-treatment of pain in PLWHA has been raised
in the literature for nearly 20 years [45, 46]. However,
the pharmacological treatment of pain in PLWHA has
limited efficacy [33] and non-pharmacological interven-
tions such as those used in other chronic pain condi-
tions are now proposed for this population [47]. Given
the pattern of pain recorded in this study, particularly
the varying sites of pain which suggest both HIV and
non-HIV related causes, non-pharmacological treat-
ments which target the biopsychosocial nature of pain
appear relevant. These non-pharmacological treatments
target the multiple variables (disease and psychosocial)
which may contribute to pain in PLWHA and include
exercise [48, 49], education [50, 51] and cognitive behav-
ioural strategies [52]. While these pain treatments alone
appear to have small effects sizes, a combination ap-
proach of exercise and education based on a chronic
pain management approach and aimed at patient em-
powerment holds promise [47, 53].
Relationship between pain and other variables
The majority of the participants (58%) were classified as
having AIDS. The CD4+ counts (330.98 ± 211.89cells/
microL) suggest that their health was relatively stable at the
time of interview, however, the range of CD4+ counts re-
flect a more diverse state of health in the sample with the
most recent counts ranging from 20–1040cells/microL.
These figures suggest that some participants were acutely
ill although only 38 participants (17%) were currently suf-
fering from an opportunistic infection. Given the wide ran-
ging sites of pain and the prevalence of head/neck and
abdominal pain, it is likely that the participants were suffer-
ing from pain not related to their HIV disease or opportun-
istic infections. In countries where ART has been made
available, the profile of HIV/AIDS has changed from that of
a terminal illness to one of a chronic debilitating disease
which has the potential to become terminal [54]. In South
Africa, a similar transition can be expected with growing
numbers of people living with HIV/AIDS living for longer
periods of time and PLWHA needing management of
widely prevalent conditions such as arthritis, hypertension
and diabetes [20]. Treatment of interdependent conditions
such as these will require patient-centred approaches which
integrate both pharmacological and non-pharmacological
treatments to enhance quality of life.
Level of education as represented by number of years of
schooling was negatively correlated to both pain severity
and pain interference scores. This association between
level of education and pain in PLWHA has previously
been identified by several authors [2, 33]. Low levels of
education are commonly associated with low levels of
health literacy, poor nutrition, poor general health and un-
employment [55]; the combination of which will contrib-
ute to individual’s vulnerability to illness and perceived
threat when they are ill. Low levels of education are rele-
vant when the literature emphasising the need to educate
persons living with chronic diseases in order to minimise
symptoms, improve adherence and HRQoL is considered
[56]. To maximise treatment efficacy, educational inter-
ventions need to be developed for the appropriate educa-
tional level and consider the need for education on a
broad range of health literacy topics.
In a cross-sectional study such as this one is not possible
to determine whether HRQoL is influenced by the pres-
ence of pain or whether a low HRQoL increases risk of
pain. While it appears intuitive to suggest that the pres-
ence of pain would reduce HRQoL, the study design limits
exploration of directionality. This limitation is not re-
stricted to the HRQoL data but similarly applies to the
directionality of relationships between pain and employ-
ment, education, self-efficacy, depression and history of
trauma. The mean score for depression on the Beck De-
pression Inventory of 17 ± 10.39 was concerning as a score
of >13 can be regarded as indicative of depressive
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symptoms. When scores for depression were explored by
group, those with pain remained above the 13-point score
(18.54 ± 10.42) while those without pain were below this
score (12.59 ± 9.04) suggesting that those with pain were
depressed [57, 58]. The links between pain and depression
are well recognised in the broader pain literature and in
studies exploring pain in PLWHA [16, 59, 60].
The study’s specific aim was to explore pain in AmaX-
hosa women living with HIV/AIDs. The sample studied
was drawn from a single site in an urban resource poor
setting, introducing a selection bias which may have in-
fluenced results. The data should thus be interpreted
with consideration of this bias.
Conclusion
This study reinforces the high prevalence, severity and
under-management of pain previously reported in
PLWHA. It also highlights that pain appears to be a com-
mon problem for amaXhosa women living with HIV/AIDS.
These data emphasise the need to prioritise the assessment
and management of pain and psychiatric comorbidities in
amaXhosa women living with HIV/AIDS and draws atten-
tion to the possible role for non-pharmacological manage-
ment approaches. Routinely assessing for the presence of
pain in women with HIV/AIDS has the potential to im-
prove pain management and minimise the impact of pain
on function.
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